Stock 002332 ZHEJIANG XIANJU PHARMACEUTICAL CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Zhejiang Xianju Pharmaceutical Co.,Ltd.

Equities

002332

CNE100000K64

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 30/05/2024 BST 		5-day change 1st Jan Change
12.16 CNY -0.82% Intraday chart for Zhejiang Xianju Pharmaceutical Co.,Ltd. -1.94% -4.78%
05-30 Zhejiang Xianju Pharmaceutical Co.,Ltd. Announces 2023 Final Profit Distribution on A Shares, Payable on 05 June 2024 CI
05-22 Zhejiang Xianju Pharmaceutical Co.,Ltd. Approves Cash Dividend for the Year 2023 CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Zhejiang Xianju Pharmaceutical Co.,Ltd. Announces 2023 Final Profit Distribution on A Shares, Payable on 05 June 2024
Zhejiang Xianju Pharmaceutical Co.,Ltd. Approves Cash Dividend for the Year 2023
Zhejiang Xianju Pharmaceutical Co.,Ltd. Proposes Final Dividend for the Year 2023
Zhejiang Xianju Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Xianju Pharma to Invest 33 Million Yuan in Local Drug R&D Firm
Hangzhou Yuhong Pharmaceutical Technology Co., Ltd. announced that it expects to receive CNY 80 million in funding from Zhejiang Xianju Pharmaceutical Co.,Ltd., Jiaxing Miyin Yuhong Equity Investment Partnership Enterprise (L.P.), Hainan Huishengde Enterprise Management Partnership Enterprise (L.P.), Hangzhou Yulin Enterprise Management Partnership Enterprise (L.P.)
Zhejiang Xianju Pharmaceutical's Flumazenil Injection Chosen for China's Centralized Bid
Zhejiang Xianju Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Zhejiang Xianju Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Zhejiang Xianju Pharmaceutical Co.,Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 02 June 2023
Zhejiang Xianju Pharmaceutical Co.,Ltd. Approves Cash Dividend for the Year 2022
Zhejiang Xianju Pharmaceutical Co.,Ltd. Proposes Final Dividend for 2022
Zhejiang Xianju Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Zhejiang Xianju Pharma’s Abortion Tablet Passes Consistency Evaluation
Zhejiang Xianju Pharma Logs 20.4% Jump in 2022 Profit
Zhejiang Xianju Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Ningbo Linghan Enterprise Management Partnership Enterprise (Limited Partnership) entered into equity transaction contract to acquire 14.60% stake in Hangzhou Weisibo Medical Technology Co., Ltd. from Zhejiang Xianju Pharmaceutical Co.,Ltd. for CNY 8 million.
Zhejiang Xianju Pharmaceutical Co.,Ltd. Approves Management Elections
Zhejiang Xianju Pharmaceutical Co.,Ltd.(SZSE:002332) dropped from Shenzhen Stock Exchange Component A Share Index
Zhejiang Xianju Pharmaceutical Co.,Ltd.(SZSE:002332) dropped from Shenzhen Stock Exchange Component Index
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 002332 Stock
  4. News Zhejiang Xianju Pharmaceutical Co.,Ltd.
  5. Other languages